Isabel Ochoa-Navas

Statistics

Publications

Citations

235

H-Index

Active since

2019

Affiliations

National Institutes of Health Clinical Center(Current)

National Heart Lung and Blood Institute

National Institutes of Health

Carolina Arthritis Associates

National Institute of Arthritis and Musculoskeletal and Skin Diseases

Isabel Ochoa-Navas is an author at National Institutes of Health Clinical Center specializing in autoimmunity, systemic lupus erythematosus, and pharmacology.

Publications per year

2019–2022

Publications

Phase 1 double-blind randomized safety trial of the Janus kinase inhibitor tofacitinib in systemic lupus erythematosus

Sarfaraz Hasni, Sarthak Gupta, Michael A. Davis et al. · Nature Communications · 2021 · 197 citations · Full text

Medicine, Immunology, Pharmacology +17

Peroxisome proliferator activated receptor-γ agonist pioglitazone improves vascular and metabolic dysfunction in systemic lupus erythematosus

Sarfaraz Hasni, Yenealem Temesgen‐Oyelakin, Michael A. Davis et al. · Annals of the Rheumatic Diseases · 2022 · 25 citations · Full text

Veterinary Medicine, Immunology, Pharmacology +17

183 A phase 1B/2A trial of tofacitinib, an oral janus kinase inhibitor, in systemic lupus erythematosus

Sarfaraz Hasni, Sarthak Gupta, Michael A. Davis et al. · Abstracts · 2019 · 13 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

1–3 of 3